Total Payments
$4,253
2024 Payments
$141.49
Companies
19
Transactions
364
Medicare Patients
1,410
Medicare Billing
$140,517
Payment Breakdown by Category
Food & Beverage$4,243 (99.8%)
Education$10.59 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,243 | 362 | 99.8% |
| Education | $10.59 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,299 | 121 | $0 (2023) |
| GlaxoSmithKline, LLC. | $601.04 | 41 | $0 (2024) |
| PFIZER INC. | $533.33 | 64 | $0 (2021) |
| Amarin Pharma Inc. | $331.72 | 26 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $292.91 | 20 | $0 (2024) |
| Novo Nordisk Inc | $283.31 | 23 | $0 (2024) |
| Lilly USA, LLC | $247.60 | 17 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $186.93 | 16 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $158.79 | 12 | $0 (2020) |
| Aralez Pharmaceuticals US Inc. | $108.26 | 10 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $141.49 | 8 | AstraZeneca Pharmaceuticals LP ($19.04) |
| 2023 | $151.69 | 9 | GlaxoSmithKline, LLC. ($72.79) |
| 2022 | $131.44 | 9 | GlaxoSmithKline, LLC. ($75.42) |
| 2021 | $440.55 | 29 | GlaxoSmithKline, LLC. ($121.67) |
| 2020 | $517.93 | 36 | Boehringer Ingelheim Pharmaceuticals, Inc. ($164.65) |
| 2019 | $631.81 | 59 | Boehringer Ingelheim Pharmaceuticals, Inc. ($214.95) |
| 2018 | $1,004 | 92 | Boehringer Ingelheim Pharmaceuticals, Inc. ($323.22) |
| 2017 | $1,234 | 122 | Boehringer Ingelheim Pharmaceuticals, Inc. ($452.78) |
All Payment Transactions
364 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Chiesi USA, Inc. | ELFABRIO (Drug) | Food and Beverage | Cash or cash equivalent | $13.96 | General |
| Category: ERT FOR FABRY DISEASE | ||||||
| 12/05/2024 | PolyNovo North America LLC | NOVOSORB BTM (Device) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: SYNTHETIC DERMAL SUBSTITUTE | ||||||
| 09/11/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.56 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Diabetes | ||||||
| 08/07/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Diabetes | ||||||
| 06/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: NEUROSCIENCE | ||||||
| 02/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: RESPIRATORY | ||||||
| 01/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/03/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: DIABETES | ||||||
| 08/24/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/14/2023 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Durable Pump | ||||||
| 05/10/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: RESPIRATORY | ||||||
| 03/21/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: RESPIRATORY | ||||||
| 03/08/2023 | Medtronic, Inc. | MINIMED 770G (Device) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Durable Pump | ||||||
| 02/15/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: RESPIRATORY | ||||||
| 01/25/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: DIABETES | ||||||
| 01/12/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: RESPIRATORY | ||||||
| 12/14/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: RESPIRATORY | ||||||
| 10/19/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/17/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: RESPIRATORY | ||||||
| 08/11/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Cardiovascular | ||||||
| 06/15/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: RESPIRATORY | ||||||
| 04/12/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/23/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: RESPIRATORY | ||||||
| 01/19/2022 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 258 | 672 | $58,454 | $26,590 |
| 2022 | 9 | 342 | 723 | $60,490 | $26,770 |
| 2021 | 7 | 373 | 978 | $87,759 | $36,321 |
| 2020 | 8 | 437 | 1,413 | $113,902 | $50,836 |
Total Patients
1,410
Total Services
3,786
Medicare Billing
$140,517
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 65 | 196 | $24,696 | $10,489 | 42.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 89 | 289 | $17,787 | $8,666 | 48.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 55 | 110 | $9,665 | $5,361 | 55.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 15 | 21 | $1,911 | $744.31 | 38.9% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 13 | 31 | $2,170 | $701.04 | 32.3% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Office | 2023 | 21 | 25 | $2,225 | $628.32 | 28.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 94 | 289 | $17,047 | $8,512 | 49.9% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 52 | 104 | $13,104 | $5,172 | 39.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 64 | 104 | $9,009 | $4,740 | 52.6% |
| 99307 | Follow-up nursing facility visit per day, typically 10 minutes | Office | 2022 | 50 | 98 | $8,722 | $2,914 | 33.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 16 | 16 | $3,056 | $1,927 | 63.0% |
| 99318 | Nursing facility annual assessment, typically 30 minutes | Office | 2022 | 22 | 22 | $3,894 | $1,562 | 40.1% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2022 | 15 | 38 | $2,660 | $1,019 | 38.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 13 | 18 | $1,638 | $542.30 | 33.1% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2022 | 16 | 34 | $1,360 | $381.85 | 28.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 126 | 459 | $35,071 | $15,167 | 43.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 81 | 155 | $17,310 | $8,458 | 48.9% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Office | 2021 | 68 | 213 | $18,957 | $6,576 | 34.7% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2021 | 36 | 50 | $6,300 | $2,490 | 39.5% |
| 99318 | Nursing facility annual assessment, typically 30 minutes | Office | 2021 | 24 | 24 | $4,248 | $1,436 | 33.8% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2021 | 23 | 54 | $3,780 | $1,367 | 36.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 15 | 23 | $2,093 | $826.74 | 39.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 173 | 824 | $53,696 | $26,089 | 48.6% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Office | 2020 | 63 | 284 | $25,276 | $9,351 | 37.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 50 | 78 | $7,547 | $3,778 | 50.1% |
About Dr. Thomas Epperson, MD
Dr. Thomas Epperson, MD is a Internal Medicine healthcare provider based in Middlesboro, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1184605966.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Epperson, MD has received a total of $4,253 in payments from pharmaceutical and medical device companies, with $141.49 received in 2024. These payments were reported across 364 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($4,243).
As a Medicare-enrolled provider, Epperson has provided services to 1,410 Medicare beneficiaries, totaling 3,786 services with total Medicare billing of $140,517. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Middlesboro, KY
- Active Since 11/09/2005
- Last Updated 10/18/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1184605966
Products in Payments
- TRELEGY ELLIPTA (Drug) $468.70
- JARDIANCE (Drug) $342.30
- Vascepa (Drug) $331.72
- STIOLTO RESPIMAT (Drug) $302.57
- STIOLTO (Drug) $273.98
- CHANTIX (Drug) $249.61
- FARXIGA (Drug) $242.18
- Victoza (Drug) $229.57
- TRULICITY (Drug) $202.00
- ENTRESTO (Drug) $186.93
- SPIRIVA RESPIMAT (Drug) $185.58
- JANUVIA (Drug) $146.34
- PRADAXA (Drug) $126.91
- LYRICA (Drug) $103.99
- YOSPRALA (Drug) $84.67
- VIAGRA (Drug) $77.92
- COLOGUARD (Device) $58.46
- TRADJENTA (Drug) $54.52
- INVOKANA (Drug) $54.14
- BREO (Drug) $53.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Middlesboro
Dr. Neil Barry, Md, MD
Internal Medicine — Payments: $2,276
Internal Medicine $2,276
Charles Moore, Md, MD
Internal Medicine — Payments: $982.11
Internal Medicine $982.11
Patrick Ball, Do, DO
Internal Medicine — Payments: $247.73
Internal Medicine $247.73
Brooke Laughter
Internal Medicine — Payments: $184.78
Internal Medicine $184.78
Nitinkumar Patel, Md, MD
Internal Medicine — Payments: $168.53
Internal Medicine $168.53
Dr. Lovie Stallworth, M.d, M.D
Internal Medicine — Payments: $71.45
Internal Medicine $71.45